| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 170.35B | 179.21B | 216.26B | 218.00B | 213.40B | 191.33B |
| Gross Profit | 23.04B | 23.74B | 26.84B | 19.22B | 22.67B | 19.28B |
| EBITDA | 15.16B | 15.97B | 21.09B | 14.27B | 19.86B | 12.31B |
| Net Income | 4.26B | 4.55B | 7.45B | 1.44B | 4.47B | -1.33B |
Balance Sheet | ||||||
| Total Assets | 174.31B | 168.41B | 185.61B | 199.63B | 208.33B | 189.18B |
| Cash, Cash Equivalents and Short-Term Investments | 45.54B | 42.76B | 49.16B | 33.70B | 42.07B | 34.05B |
| Total Debt | 2.02B | 504.00M | 4.24B | 7.43B | 11.21B | 11.17B |
| Total Liabilities | 56.31B | 56.45B | 75.35B | 101.74B | 112.98B | 103.02B |
| Stockholders Equity | 107.91B | 102.16B | 100.22B | 88.18B | 83.81B | 76.03B |
Cash Flow | ||||||
| Free Cash Flow | 5.74B | -135.00M | 18.79B | -354.00M | 6.21B | 8.17B |
| Operating Cash Flow | 11.92B | 3.82B | 22.35B | 4.06B | 12.14B | 16.15B |
| Investing Cash Flow | -5.88B | -3.48B | -3.10B | -2.81B | -3.95B | -8.69B |
| Financing Cash Flow | -1.69B | -6.49B | -6.63B | -7.68B | -2.79B | -625.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥46.39B | 7.97 | 8.46% | 2.64% | -6.35% | 18.49% | |
71 Outperform | ¥44.45B | 12.06 | ― | 2.37% | -13.35% | -19.38% | |
71 Outperform | ¥51.47B | 4.34 | ― | 3.60% | 0.14% | 882.91% | |
70 Outperform | ¥56.34B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
66 Neutral | ¥40.73B | 50.47 | ― | 5.35% | -6.20% | -64.65% | |
65 Neutral | ¥43.14B | 14.81 | 5.33% | 2.09% | 1.26% | 56.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |